• Clinically Proven Weight Loss: Saxenda has demonstrated significant weight reduction in clinical trials when combined with a reduced-calorie diet and increased physical activity.
• Appetite Suppression: Mimics the action of the natural hormone GLP-1 to promote feelings of fullness, helping patients control hunger and reduce portion sizes.
• User-Friendly Administration: The pre-filled, multi-dose pen allows for convenient once-daily subcutaneous injections, seamlessly integrating into patients’ daily routines.
• Personalized Dosage Adjustment: Gradual dose escalation from 0.6 mg to the full 3.0 mg minimizes gastrointestinal side effects and tailors the treatment to individual patient needs.
• Long-Term Weight Management: Supports sustained weight loss and helps reduce the risk of weight-related comorbidities, contributing to improved overall health.